Madheswaran T - Search Results

1

Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.

Bose RJC, Tharmalingam N, Choi Y, Madheswaran T, Paulmurugan R, McCarthy JR, Lee SH, Park H. Bose RJC, et al. Among authors: madheswaran t. Int J Nanomedicine. 2020 Oct 29;15:8437-8449. doi: 10.2147/IJN.S271850. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33162754 Free PMC article.

2

A Perspective on Therapeutic Applications and Strategies to Mitigate Toxicity of Metallic Nanoparticles.

Karuppaiah A, Selvaraj D, Sellappan M, Nagarajan A, Babu D, Rahman H, Madheswaran T, Bose B, Natrajan T. Karuppaiah A, et al. Among authors: madheswaran t. Curr Pharm Des. 2023;29(4):239-245. doi: 10.2174/1381612829666230109111635. Curr Pharm Des. 2023. PMID: 36624648

3

Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity.

Baskaran R, Madheswaran T, Sundaramoorthy P, Kim HM, Yoo BK. Baskaran R, et al. Among authors: madheswaran t. Int J Nanomedicine. 2014 Jun 26;9:3119-30. doi: 10.2147/IJN.S61823. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25061290 Free PMC article.

4

Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.

Madheswaran T, Kandasamy M, Bose RJ, Karuppagounder V. Madheswaran T, et al. Drug Discov Today. 2019 Jul;24(7):1405-1412. doi: 10.1016/j.drudis.2019.05.004. Epub 2019 May 15. Drug Discov Today. 2019. PMID: 31102731 Review.

5

Hand Sanitizers: A Review on Formulation Aspects, Adverse Effects, and Regulations.

Jing JLJ, Pei Yi T, Bose RJC, McCarthy JR, Tharmalingam N, Madheswaran T. Jing JLJ, et al. Among authors: madheswaran t. Int J Environ Res Public Health. 2020 May 11;17(9):3326. doi: 10.3390/ijerph17093326. Int J Environ Res Public Health. 2020. PMID: 32403261 Free PMC article.

6

Labeling and tracking cells with gold nanoparticles.

Chandrasekaran R, Madheswaran T, Tharmalingam N, Bose RJ, Park H, Ha DH. Chandrasekaran R, et al. Among authors: madheswaran t. Drug Discov Today. 2021 Jan;26(1):94-105. doi: 10.1016/j.drudis.2020.10.020. Epub 2020 Oct 31. Drug Discov Today. 2021. PMID: 33130336 Review.

7

Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications.

Loo YS, Bose RJ, McCarthy JR, Mat Azmi ID, Madheswaran T. Loo YS, et al. Among authors: madheswaran t. Drug Discov Today. 2021 Apr;26(4):902-915. doi: 10.1016/j.drudis.2020.12.017. Epub 2020 Dec 28. Drug Discov Today. 2021. PMID: 33383213 Review.

8

Bacterial cancer therapy: A turning point for new paradigms.

Mayakrishnan V, Kannappan P, Tharmalingam N, Bose RJC, Madheswaran T, Ramasamy M. Mayakrishnan V, et al. Among authors: madheswaran t. Drug Discov Today. 2022 Aug;27(8):2043-2050. doi: 10.1016/j.drudis.2022.03.007. Epub 2022 Mar 15. Drug Discov Today. 2022. PMID: 35304339

9

Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.

Leu JSL, Teoh JJX, Ling ALQ, Chong J, Loo YS, Mat Azmi ID, Zahid NI, Bose RJC, Madheswaran T. Leu JSL, et al. Among authors: madheswaran t. Pharmaceutics. 2023 May 6;15(5):1421. doi: 10.3390/pharmaceutics15051421. Pharmaceutics. 2023. PMID: 37242663 Free PMC article. Review.

10

Immunological axis of curcumin-loaded vesicular drug delivery systems.

Chellappan DK, Ng ZY, Wong JY, Hsu A, Wark P, Hansbro N, Taylor J, Panneerselvam J, Madheswaran T, Gupta G, Bebawy M, Hansbro PM, Dua K. Chellappan DK, et al. Among authors: madheswaran t. Future Med Chem. 2018 Apr 1;10(8):839-844. doi: 10.4155/fmc-2017-0245. Epub 2018 Apr 5. Future Med Chem. 2018. PMID: 29620416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page